© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 16, 1204-1210,
August 21, 2002
© 2002 Oxford University Press
CANCER SURVEILLANCE SERIES |
Trends in Kaposi's Sarcoma and Non-Hodgkin's Lymphoma Incidence in the United States From 1973 Through 1998
Affiliations of authors: M. A. Eltom, S. M. Mbulaiteye, S. S. Devesa, R. J. Biggar, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; A. Jemal, Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Correspondence to: Robert J. Biggar, M.D., and Mohamed A. Eltom, M.D., 6120 Executive Blvd., EPS Rm. 8015, MSC 7248, Rockville, MD 20852 (e-mail: biggarb{at}mail.nih.gov, eltomm{at}mail.nih.gov).
Background: The incidence of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL) in the general population has markedly increased since the onset of the AIDS epidemic in 1981. However, during the 1990s, the dynamics of the AIDS epidemic changed, as human immunodeficiency virus (HIV) infection rates slowed and effective antiretroviral therapies were introduced. We examined the impact of these changes on the general population incidence of KS and NHL. Methods: Age-standardized incidences for KS and NHL from 1973 through 1998 were obtained from nine population-based cancer registries that participate in the Surveillance, Epidemiology and End Results (SEER) program. Results: During the mid-1990s, KS incidence declined sharply in all nine registries. Decreases in KS incidence were most evident in San Francisco, where KS rates among white men had risen from 0.5 per 100 000 people per year in 1973 to between 31.1 and 33.3 from 1987 through 1991 and then declined to 2.8 in 1998. With background NHL incidence in the general population being much higher than that for KS, changes in incidence related to the AIDS epidemic were most evident in subgroups at high risk of AIDS. In San Francisco, NHL rates among white men rose from 10.7 in 1973 to a peak of 31.4 in 1995 and then declined to 21.6 in 1998. NHL types that were most highly AIDS-associated declined most steeply, whereas the incidence of NHL types not associated with AIDS was either stable or increasing. Conclusion: Changes in KS and NHL incidence since the mid 1990s may reflect declines in the number of individuals with AIDS and improved immune function in such individuals following the introduction of effective antiretroviral therapies in the 1990s. Notably, non-AIDS-associated NHL incidence has continued to increase steadily through 1998.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Zhang, S. D. Sanjose, P. M. Bracci, L. M. Morton, R. Wang, P. Brennan, P. Hartge, P. Boffetta, N. Becker, M. Maynadie, et al. Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma Am. J. Epidemiol., June 1, 2008; 167(11): 1321 - 1331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Patel, D. L. Hanson, P. S. Sullivan, R. M. Novak, A. C. Moorman, T. C. Tong, S. D. Holmberg, J. T. Brooks, and for the Adult and Adolescent Spectrum of Disease P Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992-2003 Ann Intern Med, May 20, 2008; 148(10): 728 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Cocco, P Brennan, A Ibba, S de Sanjose Llongueras, M Maynadie, A Nieters, N Becker, M G Ennas, M G Tocco, and P Boffetta Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes Occup. Environ. Med., February 1, 2008; 65(2): 132 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Nun, D. J. Kroll, N. H. Oberlies, D. D. Soejarto, R. J. Case, P. Piskaut, T. Matainaho, C. Hilscher, L. Wang, D. P. Dittmer, et al. Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus Mol. Cancer Ther., August 1, 2007; 6(8): 2360 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. D. Criscione and M. A. Weinstock Incidence of Cutaneous T-Cell Lymphoma in the United States, 1973-2002 Arch Dermatol, July 1, 2007; 143(7): 854 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Engel, F. Laden, A. Andersen, P. T. Strickland, A. Blair, L. L. Needham, D. B. Barr, M. S. Wolff, K. Helzlsouer, D. J. Hunter, et al. Polychlorinated Biphenyl Levels in Peripheral Blood and Non-Hodgkin's Lymphoma: A Report from Three Cohorts Cancer Res., June 1, 2007; 67(11): 5545 - 5552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Engel, Q. Lan, and N. Rothman Polychlorinated Biphenyls and Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 373 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Iregbu and O. Y. Elegba Prevalence of Kaposi's Sarcoma Among Adult HIV-Seropositive Patients Seen in a Designated HIV Treatment and Care Center in Abuja, Nigeria. J Int Assoc Physicians AIDS Care (Chic Ill), September 1, 2006; 5(3): 115 - 118. [Abstract] [PDF]
|
|
|
|
 |
|
 E. M WARD, M. J THUN, L. M HANNAN, and A. JEMAL Interpreting cancer trends. Ann. N.Y. Acad. Sci., September 1, 2006; 1076: 29 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Casper, A. S. Meier, A. Wald, R. A. Morrow, L. Corey, and A.-B. Moscicki Human Herpesvirus 8 Infection Among Adolescents in the REACH Cohort. Arch Pediatr Adolesc Med, September 1, 2006; 160(9): 937 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Moslehi, S. S. Devesa, C. Schairer, and J. F. Fraumeni Jr. Rapidly Increasing Incidence of Ocular Non-Hodgkin Lymphoma. J Natl Cancer Inst, July 5, 2006; 98(13): 936 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Clarke, D. M. Undurraga, P. J. Harasty, S. L. Glaser, L. M. Morton, and E. A. Holly Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 630 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Morton, S. S. Wang, S. S. Devesa, P. Hartge, D. D. Weisenburger, and M. S. Linet Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood, January 1, 2006; 107(1): 265 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. McGlynn, S. S. Devesa, B. I. Graubard, and P. E. Castle Increasing Incidence of Testicular Germ Cell Tumors Among Black Men in the United States J. Clin. Oncol., August 20, 2005; 23(24): 5757 - 5761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hartge, J. S. Colt, R. K. Severson, J. R. Cerhan, W. Cozen, D. Camann, S. H. Zahm, and S. Davis Residential Herbicide Use and Risk of Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 934 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global Cancer Statistics, 2002 CA Cancer J Clin, March 1, 2005; 55(2): 74 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Turner, A. M. Hughes, A. Kricker, S. Milliken, A. Grulich, J. Kaldor, and B. Armstrong Use of the WHO lymphoma classification in a population-based epidemiological study Ann. Onc., April 1, 2004; 15(4): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Clarke, S. L. Glaser, R. F. Dorfman, P. M. Bracci, E. Eberle, and E. A. Holly Expert Review of Non-Hodgkin's Lymphomas in a Population-Based Cancer Registry: Reliability of Diagnosis and Subtype Classifications Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 138 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Freemark and L. L. Levitsky Screening for Celiac Disease in Children With Type 1 Diabetes: Two views of the controversy Diabetes Care, June 1, 2003; 26(6): 1932 - 1939. [Full Text] [PDF]
|
|